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Background
Mutations in the pyrazinamidase (PZAse) coding gene,
pncA, have been considered as the main cause of pyrazina-
mide (PZA) resistance in Mycobacterium tuberculosis.
However, recent studies suggest there is no single
mechanism of resistance to PZA. The pyrazinoic acid
(POA) efflux rate is the basis of the PZA susceptibility
Wayne test, and its quantitative measurement has been
found to be a highly sensitive and specific predictor of
PZA resistance. Based on biological considerations, the
POA efflux rate is directly determined by the PZAse activ-
ity, the level of pncA expression, and the efficiency of the
POA efflux pump system. This study analyzes the indivi-
dual and the adjusted contribution of PZAse activity, pncA
expression and POA efflux rate on PZA resistance.
Methods
Thirty M. tuberculosis strains with known microbiologi-
cal PZA susceptibility or resistance were analyzed. For
each strain, PZAse was recombinantly produced and its
enzymatic activity measured. The level of pncA mRNA
was estimated by quantitative real time PCR, and the
POA efflux rate was determined. Mutations in the pncA
promoter were detected by DNA sequencing. All factors
were evaluated by multiple regression analysis to deter-
mine their adjusted effects on the level of PZA resistance.
Results and conclusions
Low level of pncA expression associated to mutations in
the pncA promoter region was observed in pncA wild-
type resistant strains. POA efflux rate was the best
predictor after adjusting for the other factors, followed
by PZAse activity.
These results suggest that tests which rely on pncA
mutations or PZAse activity are likely to be less predic-
tive of real PZA resistance than tests which measure the
rate of POA efflux. This should be further analyzed in
light of the development of alternate assays to determine
PZA resistance.
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